L-Carnitine for the treatment of highly active antiretroviral therapy-related hypertriglyceridemia in HIV-infected adults.
Loignon
M
M
Toma
E
E
D000328:Adult; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects; D001786:Blood Glucose / Q000032:analysis; D002331:Carnitine / Q000008:administration & dosage / Q000627:therapeutic use*; D002784:Cholesterol / Q000097:blood; D005260:Female; D015658:HIV Infections / Q000097:blood / Q000150:complications* / Q000821:virology; D006801:Humans; D015228:Hypertriglyceridemia / Q000097:blood / Q000139:chemically induced / Q000188:drug therapy* / Q000821:virology; D008297:Male; D010865:Pilot Projects; D011446:Prospective Studies; D012367:RNA, Viral / Q000097:blood; D016896:Treatment Outcome; D014280:Triglycerides / Q000097:blood; D019562:Viral Load
D001786:Blood Glucose; D012367:RNA, Viral; D014280:Triglycerides; D002784:Cholesterol; D002331:Carnitine